NOS2 and metabolic syndrome: ALOX-5 and ALOX-15 produce lipid signaling mediators that are known to up-regulate inducible nitric oxide synthase (iNOS). AgNP exposure was determined to reduce iNOS gene expression in only the MetS mice (Figure 4C).